Literature DB >> 2653056

Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production.

F Villemain1, L Chatenoud, A Galinowski, F Homo-Delarche, D Ginestet, H Loo, E Zarifian, J F Bach.   

Abstract

The authors examined the immune status at the cellular and humoral levels of 16 untreated schizophrenic patients. No abnormality in the distribution of T cell subsets (CD4+, CD8+) was detected. The proliferative response to the T cell mitogen phytohemagglutinin was normal. No increase in the number of T cells showing activation markers, such as human leukocyte antigens and interleukin-2 receptors, was noted. Conversely, function studies revealed a clear deficiency in interleukin-2 production by purified T cells. This lower production was probably intrinsic to the patients' T cells, since interleukin-2 production showed normal sensitivity to prostaglandin E2-mediated down-regulation by autologous monocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2653056     DOI: 10.1176/ajp.146.5.609

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  19 in total

1.  Natural killer cell function in adolescent and adult schizophrenic patients.

Authors:  Franz Resch; G Paul Amminger; Harald Aschauer; Christian Müller; Christoph Zielinski
Journal:  Eur Child Adolesc Psychiatry       Date:  1993-07       Impact factor: 4.785

Review 2.  Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.

Authors:  N Muller; M Schwarz
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

Review 3.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

Review 4.  The neuroendocrine-immune axis.

Authors:  F Homo-Delarche; M Dardenne
Journal:  Springer Semin Immunopathol       Date:  1993

Review 5.  Methodological Issues in Cytokine Measurement in Schizophrenia.

Authors:  Maju Mathew Koola
Journal:  Indian J Psychol Med       Date:  2016 Jan-Feb

6.  Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia.

Authors:  N Müller; M Empl; M Riedel; M Schwarz; M Ackenheil
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 7.  Viruses, schizophrenia, and bipolar disorder.

Authors:  R H Yolken; E F Torrey
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

8.  Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Bintou Gassama; Dale Sebastian; Peter Buckley; Andrew Mellor
Journal:  Biol Psychiatry       Date:  2012-10-11       Impact factor: 13.382

9.  Elevated Le(y) antigen expression on T-lymphocytes in schizophrenic patients.

Authors:  M Kokai; I Hirata; M Adachi; N Hatotani; S Hakomori; T Tachibana
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

10.  Association study of interleukin 2 (IL2) and IL4 with schizophrenia in a Japanese population.

Authors:  Yuichiro Watanabe; Ayako Nunokawa; Masako Shibuya; Naoshi Kaneko; Hiroyuki Nawa; Toshiyuki Someya
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-20       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.